Correlation Between Stryker and Anika Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stryker and Anika Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Anika Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Anika Therapeutics, you can compare the effects of market volatilities on Stryker and Anika Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Anika Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Anika Therapeutics.

Diversification Opportunities for Stryker and Anika Therapeutics

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Stryker and Anika is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Anika Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anika Therapeutics and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Anika Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anika Therapeutics has no effect on the direction of Stryker i.e., Stryker and Anika Therapeutics go up and down completely randomly.

Pair Corralation between Stryker and Anika Therapeutics

Considering the 90-day investment horizon Stryker is expected to generate 0.17 times more return on investment than Anika Therapeutics. However, Stryker is 5.73 times less risky than Anika Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Anika Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  36,343  in Stryker on August 31, 2024 and sell it today you would earn a total of  2,872  from holding Stryker or generate 7.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Stryker  vs.  Anika Therapeutics

 Performance 
       Timeline  
Stryker 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Stryker may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Stryker and Anika Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stryker and Anika Therapeutics

The main advantage of trading using opposite Stryker and Anika Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Anika Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anika Therapeutics will offset losses from the drop in Anika Therapeutics' long position.
The idea behind Stryker and Anika Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators